Evidence map›Paper›PMID 32283497›Full record

ReviewDiabetes & metabolic syndrome

Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians.

Amerta Ghosh, Ritesh Gupta, Anoop Misra

Erratum issuedAbstract readReview
In one paragraph

Review in Diabetes & metabolic syndrome. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 111 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pediatric endocrinopathies related to COVID-19: an update.World journal of pediatrics : WJP · 2023
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Guideline
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Amerta GhoshFortis CDOC Hospital for Diabetes and Allied Specialties, Chirag Enclave, New Delhi, India.
Ritesh GuptaFortis CDOC Hospital for Diabetes and Allied Specialties, Chirag Enclave, New Delhi, India.
Anoop MisraFortis CDOC Hospital for Diabetes and Allied Specialties, Chirag Enclave, New Delhi, India; National Diabetes, Obesity and Cholesterol Foundation, New Delhi, India; Diabetes Foundation (India), New Delhi, India. Electronic address: anoopmisra@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsIn view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario.

methodsPubMed and Google Scholar search engines were searched using the key terms 'telemedicine', 'diabetes', 'COVID-19 up to 31

resultsWe discuss evidence and general guidelines regarding role of telemedicine in patients with diabetes along with its utility and limitations.

conclusionsTelemedicine is a useful tool for managing patients of diabetes during this lockdown period. However, there is limited data and further research is required.

Indexed as

BetacoronavirusPandemicsTelemedicineCoronavirus InfectionsCOVID-19Diabetes MellitusFeasibility StudiesHumansIndiaPneumonia, ViralPractice Guidelines as TopicPubMedSARS-CoV-2

Identifiers

PMID32283497
PMCPMC7129346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.